There are currently 13 active clinical trials seeking participants for Benign Prostatic Hyperplasia research studies. The states with the highest number of trials for Benign Prostatic Hyperplasia participants are California, Florida, New York and Texas.
OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH
NCT06560476
Recruiting
APEX is a prospective multi-site registry of real-world experience with the Optilume™ BPH Catheter System for treatment of men experiencing symptomatic BPH.
Gender:
MALE
Ages:
All
Trial Updated:
01/20/2025
Locations: Golden State Urology, Sacramento, California +5 locations
Conditions: Benign Prostatic Hyperplasia
Register for Updates
Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization
NCT04879940
Recruiting
This is a Phase II prospective clinical trial in which patients with prostate carcinoma and obstructive lower urinary tract symptoms electing for radiation therapy will undergo Prostatic Artery Embolization (PAE) prior to treatment. PAE will be administered by Interventional Radiology. Patients will be seen for follow-up at 6 weeks and 12 weeks following PAE after which they will start definitive radiotherapy. After completion of radiotherapy the patient will be seen at 12 weeks
Gender:
MALE
Ages:
50 years and above
Trial Updated:
01/07/2025
Locations: Moffitt Cancer Center, Tampa, Florida
Conditions: Prostate Carcinoma, Benign Prostatic Hyperplasia
Register for Updates
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
NCT06511141
Recruiting
To assess the post-market clinical outcomes of the Axonics SNM System for treatment of overactive bladder in male patients.
Gender:
MALE
Ages:
Between 18 years and 75 years
Trial Updated:
12/10/2024
Locations: El Camino Health, Mountain View, California +3 locations
Conditions: Overactive Bladder, Urinary Urgency Incontinence, Benign Prostatic Hyperplasia, Prostate Cancer, Prostatectomy
Register for Updates
Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported Outcomes
NCT05898932
Recruiting
The goal of this project is to use newly developed patient-reported outcomes to improve the clinical care of patients with benign prostatic hyperplasia. The use of new patient-centered tools will improve evaluation and clinical decision-making by including symptoms not commonly measured in men, such as urinary incontinence, and allow for more frequent assessment of lower urinary tract symptoms through remote surveillance. Through the use of care-coordination checklists, clinicians can be more re... Read More
Gender:
MALE
Ages:
50 years and above
Trial Updated:
11/15/2024
Locations: NorthShore University HealthSystem Research Institute, Glenview, Illinois
Conditions: Benign Prostatic Hyperplasia
Register for Updates
PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs
NCT06051942
Recruiting
The goal of this clinical trial is to assess the performance and safety of the AQUABEAM Robotic System for the resection and removal of prostate tissue in patients experiencing lower urinary tract symptoms (LUTS) and are diagnosed with localized prostate cancer. Participants will go through baseline and follow up assessments up to 12 months.
Gender:
MALE
Ages:
80 years and below
Trial Updated:
11/15/2024
Locations: San Diego Clinical Trials, La Mesa, California +5 locations
Conditions: Benign Prostatic Hyperplasia, Localized Prostate Cancer
Register for Updates
Customized TULSA-PRO Ablation Registry
NCT05001477
Recruiting
This patient registry will capture data from patients who have been or who are undergoing the transurethral ultrasound ablation (TULSA) procedure as part of their routine clinical care. The registry will shed light on real-world outcomes of safety and efficacy of the procedure and understand how a patient's quality of life is affected throughout their follow-up and lifetime.
Gender:
MALE
Ages:
18 years and above
Trial Updated:
11/05/2024
Locations: RadNet's Liberty Pacific West Hills Facility, West Hills, California +4 locations
Conditions: Prostate Cancer, Prostate Adenocarcinoma, Benign Prostatic Hyperplasia
Register for Updates
Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study
NCT06312722
Recruiting
The goal of this clinical trial is to verify the continued safety and effectiveness for the Optilume BPH Catheter System.
Gender:
MALE
Ages:
50 years and above
Trial Updated:
11/04/2024
Locations: Arkansas Urology, Little Rock, Arkansas +4 locations
Conditions: Benign Prostatic Hyperplasia
Register for Updates
Moses Vaporization: Is Use of Moses 2.0 in Holmium Laser Ablation of the Prostate More Efficient
NCT04979143
Recruiting
To determine if use of Moses 2.0 results in improved ablation efficiency during holmium laser vaporization of the prostate. To determine if use of Moses 2.0 results in less char, improved visibility, and improved hemostasis in prostate vaporization.
Gender:
MALE
Ages:
18 years and above
Trial Updated:
10/10/2024
Locations: University of Kansas Medical Center, Kansas City, Kansas
Conditions: Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms
Register for Updates
IIT-2022-Simultaneous Urolift™ and Median Lobe Enucleation
NCT06157164
Recruiting
To evaluate postoperative outcomes of BPH/Lower urinary tract symptoms, erectile function, and ejaculatory capacity of simultaneous UroLiftTM and Holmium laser enucleation of the prostatic median lobe.
Gender:
MALE
Ages:
45 years and above
Trial Updated:
09/30/2024
Locations: University of Kansas Medical Center, Kansas City, Kansas
Conditions: Benign Prostatic Hyperplasia
Register for Updates
Comparing UroLift Experience Against Rezūm
NCT04338776
Recruiting
C.L.E.A.R. Study is poised to compare the patient experience post procedure, including catheterization needs as well as retreatment and BPH medication rates following treatment with either the UroLift® System or Rezūm™ System through 12 months.
Gender:
Male
Ages:
50 years and above
Trial Updated:
05/01/2024
Locations: Tower Urology, Los Angeles, California +8 locations
Conditions: Benign Prostatic Hyperplasia
Register for Updates
5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy
NCT04288427
Recruiting
The study is being conducted to learn why some patients with Benign Prostatic Hyperplasia (BPH) do not respond to a commonly used treatment drug, Finasteride. The hope is to find ways to predict which patients will not respond to Finasteride so that, in the future, these patients can be identified prior to offering this treatment and they can be offered alternative treatment strategies in its place. The aim is to see if noninvasive techniques such as MRI can detect inflammation of the prostate t... Read More
Gender:
Male
Ages:
50 years and above
Trial Updated:
03/27/2024
Locations: Beth Israel Deaconess Medical Center, Boston, Massachusetts
Conditions: Benign Prostatic Hyperplasia, Prostate Hyperplasia, Prostate Disease, Prostate Hypertrophy, Prostate Pain, Lower Urinary Tract Symptoms, Urinary Obstruction, Urinary Tract Disease
Register for Updates
BPH Global Registry
NCT05543200
Recruiting
Benign prostatic hyperplasia (BPH) is one of the most common performed surgical procedures in urology. Over the past few decades there have been an increasing development of newer surgical treatment options. Additionally, the outcome parameters for BPH treatments have been standardized. While data are available for the initial pivotal studies, post-market release data are lacking. Under the umbrella of uCARE, we have started a prospective, ongoing international registry for recording demographic... Read More
Gender:
Male
Ages:
18 years and above
Trial Updated:
03/11/2024
Locations: Keck Medicine of USC, Los Angeles, California +6 locations
Conditions: Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms
Register for Updates